Stroke in diabetic and non-diabetic patients: Course and prognostic value of admission serum glucose

Annals of Medicine

Volumn 37, Issue 5, 2005, Pages 357-364

  Stöllberger, Claudia ^a,c   Exner, Isabella ^b   Finsterer, Josef ^a   Slany, Jörg ^a   Steger, Christina ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b First Medical Department   (Austria)

^c NONE   (Austria)

Author keywords

Case fatality; Hyperglycemia; Neurological outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPYRETIC ANALGESIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; INSULIN;

AGED; ARTICLE; AUSTRIA; BRAIN HEMORRHAGE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL DEPARTMENT; HUMAN; HYPERGLYCEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STROKE;

AGED; AGED, 80 AND OVER; AUSTRALIA; BLOOD GLUCOSE; CEREBROVASCULAR ACCIDENT; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MORTALITY; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 25644435034     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890510037356     Document Type: Article

References (32)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120-6.
2. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke. 1996;27:210-5.
3. Haheim LL, Holme I, Hjermann I, Leren P. Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study. Stroke. 1995;26:774-7.
4. Hart CL, Hole DJ, Smith GD. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke. 1999;30:1999-2007.
5. Olsson T, Viitanen M, Asplund K, Eriksson S, Hägg E. Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia. 1990;33:244-9.
6. Lithner F, Asplund K, Eriksson S, Hägg E, Strand T, Wester PO. Clinical characteristics in diabetic stroke patients. Diabet Metab. 1988;14:15-9.
7. Woo J, Lam CWK, Kay R, Wong AHY, Teoh R, Nicholls MG. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol. 1990;47:1174-7.
8. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263-70.
9. Toni D, Sacchetti ML, Argentine C, Gentile M, Cavalletti C, Frontoni M, et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol. 1992;239:382-6.
10. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke. 1994;25:1977-84.
11. Topic E, Pavlicek I, Brinar V, Korsic M. Glycosylated haemoglobin in clarification of the origin of hyperglycaemia in acute cerebrovascular accident. Diabet Med. 1989;6: 12-5.
12. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling, et al., for the European BIOMED Study of Stroke Care Group. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from the European BIOMED Stroke Project. Stroke. 2003;34:688-94.
13. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. A systematic overview. Stroke. 2001;32:2426-32.
14. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71.
15. Slany J, Lenzhofer R, Kaiser R, Exner I, Schmid W, Hügel H, et al., für die Arbeitsgemeinschaft internistisches Insultregister. Insultbehandlung an internen Abteilungen. Eine österreichische Multizenterstudie. Dtsch Med Wochenschr. 2002;127:1575-80.
16. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Maryland State Med J. 1965;14:61-5.
17. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-7.
18. Brott T, Adams HP Jr., Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-70.
19. Karapanayiotides Th, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004;62:1558-62.
20. Steiner MM, Brainin M. Austrian Stroke Registry for Acute Stroke Units. The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units. Eur J Neurol. 2003;10:353-60.
21. Rodriguez BL, D'Agostino R, Abbott RD, Kagan A, Burchfiel CM, Yano K, et al. Risk of hospitalised stroke in men enrolled in the Honolulu Heart Program and the Framingham Study. A comparison of incidence and risk factor effects. Stroke. 2002;33:230-7.
22. Alex M, Baron EK, Goldenberg S, Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation. 1962;25:663-73.
23. McCuskey PA, McCuskey RS. In vivo and electron microscopic study of the development of cerebral diabetic microangiography. Microcirc Endothelium Lymphatics. 1984;1: 221-44.
24. Powell HC, Rosoff J, Myers RR. Microangiopathy in human diabetic neuropathy. Acta Neuropathol (Berl). 1985;68: 295-305.
25. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003;34:1235-41.
26. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34: 2208-14.
27. Bruno A, Biller J, Adams HP Jr., Clarke WR, Woolson RF, Williams LS, et al., for the Trial of ORG in Acute Stroke Treatment (TOAST) Investigators. Acute blood glucose level and outcome from ischemic stroke. Neurology. 1999;52:280-4.
28. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ. 1997;314:1303-6.
29. 2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999;30:160-70.
30. Coutinho M, Wang Y, Gerstein HC, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233-40.
31. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg. 1995;82:262-8.
32. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KGMM, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia. The Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793-9.